Bristol-Myers (BMY) says European regulators have approved its drug Yervoy for treatment of...

|About: Bristol-Myers Squibb Company (BMY)|By:, SA News Editor

Bristol-Myers (BMY) says European regulators have approved its drug Yervoy for treatment of metastatic melanoma, a deadly type of skin cancer. The drug is already approved in the U.S. and is the first therapy to win marketing approval in Europe for treating late-stage melanoma in over 20 years. Shares are flat premarket.